Additionally, we also identified a few potential drugs that could be useful in the treatment of BLCA, HNSC, KIRP, LUAD, and UCEC by regulating the MTHFD1L expression (Figure 16). This evidence concerns the gene MTHFD1L and bladder transitional cell carcinoma.